GTP BIOLOGICS : revenue, balance sheet and financial ratios

GTP BIOLOGICS is a French company founded 5 years ago, specialized in the sector Fabrication de produits pharmaceutiques de base. Based in SAINT-JULIEN-EN-GENEVOIS (74160), this company of category GE shows in 2024 a revenue of 2.7 M€. Find below the complete financial statements, solvency ratios, working capital requirements and sector comparison.

Data updated on 2026-05-09

Sources : INPI & INSEE SIRENE - Processing : Ministry of Economy

Financial history - GTP BIOLOGICS (SIREN 884035718)
Indicator 2024 2023 2022 2021 2020
Revenue 2 658 874 € 7 086 000 € 10 457 000 € 6 857 267 € 1 088 300 €
Net income -6 741 851 € -2 209 000 € -237 000 € -581 694 € 315 888 €
EBITDA -4 574 577 € -1 601 000 € 420 000 € -746 376 € 459 604 €
Net margin -253.6% -31.2% -2.3% -8.5% 29.0%

Revenue and income statement

In 2024, GTP BIOLOGICS achieves revenue of 2.7 M€. Over the period 2020-2024, the company shows strong growth with a CAGR (compound annual growth rate) of +25.0%. Significant drop of -62% vs 2023. After deducting consumption (370 €), gross margin stands at 2.7 M€, i.e. a rate of 100%. This ratio measures the ability to generate value from commercial activity. EBITDA (= Gross margin - Personnel expenses - Taxes) reaches -4.6 M€, representing -172.0% of revenue. Warning negative scissor effect: despite revenue change (-62%), EBITDA varies by -186%, reducing margin by 149.5 pts. This reflects costs rising faster than revenue. Negative EBITDA means operations do not cover current expenses: concerning situation. Net income is negative at -6.7 M€ (-253.6% of revenue), which will impact equity.

Revenue (2024) ?
Revenue
Definition
Total amount of sales of goods and services made by the company.
Formula
Sales of goods + Sold production

2 658 874 €

Gross margin (2024) ?
Gross margin
Definition
Difference between revenue and cost of goods sold.
Formula
Revenue - Cost of goods consumed

2 658 504 €

EBITDA (2024) ?
Gross Operating Surplus (EBITDA)
Definition
Resources generated by current operations, before depreciation and financial expenses.
Formula
Value added - Personnel expenses - Taxes
Interpretation
Positive = profitable activity

-4 574 577 €

EBIT (2024) ?
EBIT (Operating Income)
Definition
Operating income, including depreciation and provisions.
Formula
EBITDA - Depreciation and provisions + Reversals

-5 314 900 €

Net income (2024) ?
Net income
Definition
Profit or loss after all expenses, including taxes and exceptional items.
Formula
Current income + Exceptional income - Income tax

-6 741 851 €

EBITDA margin (2024) ?
EBITDA margin
Definition
Measures the company's operating profitability.
Formula
(EBE / CA) x 100
Interpretation
> 10% : Good profitability
5-10% : Average
< 5% : Low

-169.7%

Loading income statement...

Chart evolution

Show :

Assets

Loading data...

Liabilities

Loading data...

Solvency and debt ratios

The debt ratio (= Financial debt / Equity x 100) stands at -127%. This very low level reflects a solid financial structure, offering significant room for future investments or acquisitions. Financial autonomy (= Equity / Total assets x 100) reaches -149%. Low autonomy: the company heavily depends on external financing (banks, suppliers).

Debt ratio (2024) ?
Debt ratio
Definition
Measures the proportion of debt to equity.
Formula
(Financial debt / Equity) x 100
Interpretation
< 50% : Low
50-100% : Moderate
> 100% : High

-126.607%

Financial autonomy (2024) ?
Financial autonomy
Definition
Share of equity in the company's total financing.
Formula
(Equity / Total assets) x 100
Interpretation
> 30% : Good autonomy
20-30% : Average
< 20% : Low

-148.979%

Cash flow / Revenue (2024) ?
Cash flow / Revenue
Definition
Self-financing capacity relative to revenue.
Formula
(CAF / CA) x 100
Interpretation
The higher the ratio, the more cash the company generates

-237.037%

Repayment capacity (2024) ?
Repayment capacity
Definition
Number of years needed to repay debts with cash flow.
Formula
Financial debt / Cash flow
Interpretation
< 3 years : Excellent
3-5 years : Fair
> 5 years : Warning

-1.849

Asset age ratio (2024) ?
Asset age ratio
Definition
Measures the degree of wear of tangible assets.
Formula
Accumulated depreciation / Gross fixed assets x 100
Interpretation
< 50% : Recent assets
50-70% : Normal wear
> 70% : Aging assets

57.4%

Solvency indicators evolution
GTP BIOLOGICS

Sector positioning

Debt ratio
-126.61 2024
2022
2023
2024
Q1: 0.0
Med: 3.24
Q3: 65.34
Excellent -6 pts over 3 years

In 2024, the debt ratio of GTP BIOLOGICS (-126.61) ranks in the bottom 25% of the sector, which is positive. This ratio measures the weight of debt relative to equity. A low ratio indicates a solid financial structure with little dependence on creditors.

Financial autonomy
-148.98% 2024
2022
2023
2024
Q1: 17.24%
Med: 45.12%
Q3: 75.14%
Watch -17 pts over 3 years

In 2024, the financial autonomy of GTP BIOLOGICS (-149.0%) ranks in the bottom 25% of the sector. This ratio represents the share of equity in total financing. Low autonomy may limit investment capacity and increase vulnerability.

Repayment capacity
-1.85 years 2024
2022
2023
2024
Q1: -1.5 years
Med: 0.0 years
Q3: 1.31 years
Excellent -25 pts over 3 years

In 2024, the repayment capacity of GTP BIOLOGICS (-1.85) ranks in the bottom 25% of the sector, which is positive. This ratio indicates the number of years needed to repay debt with cash flow. A short capacity reflects controlled debt and good cash generation.

Liquidity ratios

The liquidity ratio (= Current assets / Current liabilities) stands at 93.16. Concretely, the company has €2 of liquid assets for every €1 of short-term debt: no cash risk within 12 months.

Liquidity ratio (2024) ?
Liquidity ratio
Definition
Ability to meet short-term debts with current assets.
Formula
Current assets / Current liabilities
Interpretation
> 1.5 : Very good
1-1.5 : Fair
< 1 : Liquidity risk

93.162

Interest coverage (2024) ?
Interest coverage
Definition
Ability to cover interest charges with operating income.
Formula
EBIT / Interest expenses
Interpretation
> 3 : Comfortable
1.5-3 : Acceptable
< 1.5 : Risk

-5.159

Liquidity indicators evolution
GTP BIOLOGICS

Sector positioning

Liquidity ratio
93.16 2024
2022
2023
2024
Q1: 92.26
Med: 208.82
Q3: 371.21
Average +23 pts over 3 years

In 2024, the liquidity ratio of GTP BIOLOGICS (93.16) ranks below the median of the sector. This ratio measures the ability to cover short-term debt with current assets. An improvement would strengthen the competitive position.

Interest coverage
-5.16x 2024
2022
2023
2024
Q1: 0.0x
Med: 0.82x
Q3: 13.45x
Watch -62 pts over 3 years

In 2024, the interest coverage of GTP BIOLOGICS (-5.2x) ranks in the bottom 25% of the sector. This ratio indicates how many times operating income covers interest expenses. Low coverage may indicate fragility to rate or income variations.

Working capital requirement (WCR) and payment terms

Working capital requirement (WCR) measures the cash timing gap between customer collections and supplier/inventory payments. Average customer payment term: 172 days (formula: Customer receivables / Revenue incl. VAT x 360). Supplier term: 125 days. The gap of 47 days means the company finances its customers for over a month before being paid relative to supplier payments. This weighs on cash flow. Inventory turnover is 81 days (= Average inventory / Cost of goods x 360). Overall, WCR represents 134 days of revenue, i.e. 987 k€ to permanently finance. Over 2020-2024, WCR increased by +168%, requiring additional financing.

Operating WCR (2024) ?
Operating WCR
Definition
Financing requirement generated by the operating cycle (inventory + receivables - trade payables).
Formula
Inventory + Customer receivables - Trade payables
Interpretation
Negative = cash released
Positive = financing needed

986 947 €

Customer credit (2024) ?
Customer credit (days)
Definition
Average payment term granted to customers.
Formula
(Customer receivables / Revenue incl. VAT) x 360
Interpretation
< 45j : Good
45-60j : Average
> 60j : Long

172 j

Supplier credit (2024) ?
Supplier credit (days)
Definition
Average payment term obtained from suppliers.
Formula
(Trade payables / Purchases incl. VAT) x 360
Interpretation
The longer the term, the better for cash flow

125 j

Inventory turnover (2024) ?
Inventory turnover (days)
Definition
Average storage duration for goods or materials.
Formula
(Inventory / Cost of goods) x 360
Interpretation
The lower the ratio, the faster the turnover

81 j

WCR in days of revenue (2024) ?
WCR in days of revenue
Definition
Expresses working capital requirement in days of revenue.
Formula
(Operating WCR / Revenue) x 360
Interpretation
The fewer days, the better the working capital management

134 j

WCR and payment terms evolution
GTP BIOLOGICS

Positioning of GTP BIOLOGICS in its sector

Comparison with sector Fabrication de produits pharmaceutiques de base

Similar companies (Fabrication de produits pharmaceutiques de base)

Compare GTP BIOLOGICS with other companies in the same sector:

Voir toutes les statistiques du secteur Fabrication de produits pharmaceutiques de base

Frequently asked questions about GTP BIOLOGICS

What is the revenue of GTP BIOLOGICS ?

The revenue of GTP BIOLOGICS in 2024 is 2.7 M€.

Is GTP BIOLOGICS profitable?

GTP BIOLOGICS recorded a net loss in 2024.

Where is the headquarters of GTP BIOLOGICS ?

The headquarters of GTP BIOLOGICS is located in SAINT-JULIEN-EN-GENEVOIS (74160), in the department Haute-Savoie.

Where to find the tax return of GTP BIOLOGICS ?

The tax return of GTP BIOLOGICS is available on this page. Click on a year in the 'Data by year' section to view the account details (assets, liabilities, income statement). Data comes from INPI (National Institute of Industrial Property).

In which sector does GTP BIOLOGICS operate?

GTP BIOLOGICS operates in the sector Fabrication de produits pharmaceutiques de base (NAF code 21.10Z). See the 'Sector positioning' section above to compare the company with its competitors.